Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2011, Article ID 738271, 7 pages
http://dx.doi.org/10.1155/2011/738271
Research Article

Estimating the Impact and Cost of the WHO 2010 Recommendations for Antiretroviral Therapy

1Futures Institute, 41-A New London Turnpike, Glastonbury, CT 06033, USA
2UNAIDS, Avenue Appia 20, 1211 Genève, Switzerland

Received 14 June 2010; Accepted 25 October 2010

Academic Editor: Esper Kallas

Copyright © 2011 John Stover et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, “Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach, 2010 revision,” http://www.who.int/hiv/pub/arv/adult2010/en/index.html.
  2. M. A. Adam and L. F. Johnson, “Estimation of adult antiretroviral treatment coverage in South Africa,” South African Medical Journal, vol. 99, no. 9, pp. 661–667, 2009. View at Google Scholar · View at Scopus
  3. J. Stover, P. Johnson, B. Zaba, M. Zwahlen, F. Dabis, and R. E. Ekpini, “The spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds,” Sexually Transmitted Infections, vol. 84, supplement 1, pp. i24–i30, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Auvert, S. Males, A. Puren, D. Taljaard, M. Caraël, and B. Williams, “Can highly active antiretroviral therapy reduce the spread of HIV?: a study in a township of South Africa,” Journal of Acquired Immune Deficiency Syndromes, vol. 36, no. 1, pp. 613–621, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Connelly, Y. Veriava, S. Roberts et al., “Prevalence of HIV infection and median CD4 counts among health care workers in South Africa,” South African Medical Journal, vol. 97, no. 2, pp. 115–120, 2007. View at Google Scholar · View at Scopus
  6. T. M. Rehle and O. Shisana, “Estimates of eligibility for antiretroviral treatment (ART) and projected ART impact on AIDS mortality among South African educators,” Journal of Social Aspects of HIV/AIDS, vol. 2, no. 3, pp. 304–310, 2005. View at Google Scholar · View at Scopus
  7. C. B. Holmes, R. Wood, M. Badri et al., “CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment,” Journal of Acquired Immune Deficiency Syndromes, vol. 42, no. 4, pp. 464–469, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. N. McGrath, K. Kranzer, J. Saul et al., “Estimating the need for antiretroviral treatment and an assessment of a simplified HIV/AIDS case definition in rural Malawi,” AIDS, vol. 21, supplement 6, pp. S105–S113, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. National AIDS and STI Control Programme, Ministry of Health, Kenya AIDS Indicator Survey 2007: Preliminary Report, National AIDS and STI Control Programme, Ministry of Health, Nairobi, Kenya, 2008.
  10. J. Todd, J. R. Glynn, M. Marston et al., “Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy,” AIDS, vol. 21, supplement 6, pp. S55–S63, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. WHO, Futures Institute, UNAIDS, “Antiretroviral medicines in low- and middle- income countries: usage in 2008 and a demand forecast for 2010–2012 with a special focus on sub-Saharan Africa,” Forthcoming, 2010.
  12. S. A. Bautista, T. Dmytraczenko, G. Kombe, and S. M. Bertozzi, “Costing of HIV/AIDS treatment in Mexico,” PHRPlus Report, June 2003. View at Google Scholar
  13. R. Chandler and R. Musau, “Estimating resource requirements for scaling up antiretroviral therapy in Uganda,” PHRPlus Paper, October 2005. View at Google Scholar
  14. S. M. Cleary, D. McIntyre, and A. M. Boulle, “The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa—a primary data analysis,” Cost Effectiveness and Resource Allocation, vol. 4, article 20, 2006. View at Publisher · View at Google Scholar
  15. S. J. Goldie, Y. Yazdanpanah, E. Losina et al., “Cost-effectiveness of HIV treatment in resource-poor settings—the case of Côte d'Ivoire,” New England Journal of Medicine, vol. 355, no. 11, pp. 1141–1153, 2006. View at Publisher · View at Google Scholar
  16. J. Huddart, R. Furth, and J. V. Lyons, “The Zambia Workforce Study: Preparing for Scale-up,” April 2004, http://www.qaproject.org.
  17. T. Kitajima, Y. Kobayashi, W. Chaipah, H. Sato, W. Chadbunchachai, and R. Thuennadee, “Costs of medical services for patients with HIV/AIDS in Khon Kaen, Thailand,” AIDS, vol. 17, no. 16, pp. 2375–2381, 2003. View at Publisher · View at Google Scholar
  18. G. Kombe, D. Galaty, R. Gadhia, and C. Decker, “The Human and Financial Resource Requiremens for Scaling Up HIV/AID Services in Ethiopia,” PHRPlus, February 2005.
  19. G. Kombe and O. Smith, “The costs of anti-retroviral treatment in Zambia,” PHRPlus Project, October 2003. View at Google Scholar
  20. PHRPlus, “Rapid Assessment of HIV/AIDS Care in the Public and Private Sectors,” PHRPlus, Nigeria, August 2004.
  21. M. Badri, G. Maartens, S. Mandalia et al., “Cost-effectiveness of highly active antiretroviral therapy in South Africa,” PLoS Medicine, vol. 3, no. 1, article e4, pp. 48–56, 2006. View at Publisher · View at Google Scholar
  22. WHO, “WHO-CHOICE database,” June 2010, http://www.who.int/choice/costs/en.
  23. UNAIDS, “Financial Resources Required to Achieve Universal Access to HIV Prevention, Treatment, Care and Support,” February 2009, http://data.unaids.org/pub/Report/2007/jc1678_fin_res_req_en.pdf.